The serum AFP-L3 levels in early stage HCC patients (median=3.25 ng/mL) were higher than in LC patients (median=0.42 ng/mL, p<0.05), suggesting that AFP-L3 may have a clinical value for the diagnosis of early HCC. Here, AFP is linked to hepatocellular carcinoma.